Completed PHASE4 INTERVENTIONAL 2-arm NCT02035111

A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

To Evaluate the Safety and the Efficacy of Tianshu Capsule Treating Migraine in a Randomized, Placebo-Controlled, Double-blind, Multicenter Study.

Sponsor: Beijing Bionovo Medicine Development Co., Ltd.

Conditions Migraine

Interventions Sugar pill Tianshu capsule

Updated 5 times since 2017 Last updated: Apr 13, 2016 Started: Mar 31, 2014 Primary completion: Apr 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Migraine, this trial is completed. The trial is conducted by Beijing Bionovo Medicine Development Co., Ltd. and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Bionovo Medicine Development Co., Ltd.
Jiangsu Kanion Pharmaceutical Co., Ltd

Data source: Jiangsu Kanion Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Cangzhou, China , Changchun, China , Huaibei, China , Jinan, China , Jining, China , Kaifeng, China , Langfang, China , Luohe, China , Quanzhou, China and 7 more locations